Epigenetics of regional lymph node metastasis in solid tumors

Area of Science:

• Oncology
• Molecular Biology
• Cancer Epigenetics

Background:

• Regional lymph node status is a critical prognostic factor in solid tumors like melanoma, breast, and colorectal cancers.
• Even with accurate lymph node (LN) staging, LN-negative patients face risks of recurrence and distant metastasis.
• Genetic and transcriptome studies have sought molecular predictors of aggressive disease, with recent focus on epigenetic alterations.

Purpose of the Study:

• To review recent studies on regional lymph node metastases in melanoma, breast cancer, and colorectal cancer.
• To highlight the potential clinicopathological utility of epigenetic aberrations in cancer management.
• To explore epigenetic alterations as diagnostic and prognostic biomarkers for improved patient stratification.

Main Methods:

• Literature review of recent studies on epigenetic aberrations in regional lymph node metastases.
• Focus on melanoma, breast cancer, and colorectal cancer.
• Analysis of epigenetic alterations' association with tumorigenesis, disease progression, and clinical outcomes.

Main Results:

• Epigenetic aberrations are increasingly investigated in solid cancers and linked to tumorigenesis and progression.
• These alterations show potential as diagnostic and prognostic biomarkers.
• Epigenetic changes are reversible, offering avenues for targeted treatment strategies.

Conclusions:

• Epigenetic aberrations in regional lymph nodes offer significant potential as biomarkers.
• Accurate identification of high-risk patients through epigenetic analysis can guide treatment and follow-up.
• Further research into epigenetic modifications may lead to novel therapeutic approaches and improved cancer patient management.